Olpasiran trials of Cardiovascular Events lipoproteiN(a) reduction – Dose Finding Study (OCEAN(a)-DOSE) (NCT04270760)

Educational Partners and Supporters

Novartis has provided with arm’s length sponsorship towards the set-up of the Lp(a) Forum. The content was developed independently by the Forum. (Founding Partner)